Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
May 15, 2019 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, May 15, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company focused on treating...
GTX Signs Collaboration Agreement with Flint Rehab
February 06, 2019 08:35 ET
|
GTX Corp
LOS ANGELES, CALIFORNIA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- GTX Corp (OTCQB: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS, human and asset tracking systems and wandering...
The Greater Cannabis Company Announces Distribution Agreement With Leading Global Cannabis Company iCAN: Israel Cannabis Ltd.
January 07, 2019 08:30 ET
|
The Greater Cannabis Company, Inc.
Expanded Distribution to Accelerate Commercialization of Eluting Patch Platform into the Global Marketplace Baltimore, MD, Jan. 07, 2019 (GLOBE NEWSWIRE) -- The Greater Cannabis Company, Inc. (OTC:...
Carahsoft Awarded National Institutes of Health Contract to Drive Innovation in the Cloud
November 29, 2018 09:55 ET
|
Carahsoft Technology Corporation
RESTON, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced that it will be working with the National Institutes of...
Organization announces Early Career Research Award in the field of celiac disease
October 18, 2018 15:47 ET
|
Beyond Celiac
Philadelphia, PA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Beyond Celiac is announcing the creation of the Society for the Study of Celiac Disease - Beyond Celiac Early Career Research Award, a joint...
The Greater Cannabis Company Appoints Dr. Hock Tan as Chairman of Scientific Advisory Board
October 04, 2018 08:45 ET
|
The Greater Cannabis Company, Inc.
Baltimore, MD, Oct. 04, 2018 (GLOBE NEWSWIRE) -- The Greater Cannabis Company, Inc. (OTCPK: GCAN) (“the Company”) a biotechnology company focused on innovative delivery systems for the Cannabis...
RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea
November 30, 2017 08:45 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J, Nov. 30, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”) announces that the results of the PACE (Pharmacotherapy of Apnea by...
Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications
June 20, 2017 16:01 ET
|
Trevena Inc.
KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis:...
Rheumatology Leaders Oppose Sweeping Healthcare Cuts in Trump Administration Budget
May 23, 2017 16:51 ET
|
American College of Rheumatology
Atlanta, May 23, 2017 (GLOBE NEWSWIRE) -- ATLANTA – The American College of Rheumatology (ACR) today expressed opposition to the Trump Administration’s proposed budget cuts to federal programs and...
Brain Tumor Patient Advocates Take Their Message to Congress
May 09, 2017 09:30 ET
|
National Brain Tumor Society
WASHINGTON, DC--(Marketwired - May 09, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today has gathered approximately...